vs
Side-by-side financial comparison of James River Group Holdings, Inc. (JRVR) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
James River Group Holdings, Inc. is the larger business by last-quarter revenue ($151.4M vs $76.2M, roughly 2.0× VIEMED HEALTHCARE, INC.). On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -12.1%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -10.3%).
James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
JRVR vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.4M | $76.2M |
| Net Profit | — | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | — | 7.4% |
| Revenue YoY | -12.1% | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | — | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $151.4M | — | ||
| Q4 25 | $167.7M | $76.2M | ||
| Q3 25 | $172.7M | $71.9M | ||
| Q2 25 | $174.8M | $63.1M | ||
| Q1 25 | $172.3M | $59.1M | ||
| Q4 24 | $126.7M | $60.7M | ||
| Q3 24 | $191.5M | $58.0M | ||
| Q2 24 | $188.3M | $55.0M |
| Q1 26 | — | — | ||
| Q4 25 | $32.1M | $5.6M | ||
| Q3 25 | $1.0M | $3.5M | ||
| Q2 25 | $4.8M | $3.2M | ||
| Q1 25 | $9.6M | $2.6M | ||
| Q4 24 | $-64.8M | $4.3M | ||
| Q3 24 | $-39.4M | $3.9M | ||
| Q2 24 | $7.6M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 14.6% | 11.0% | ||
| Q3 25 | 1.5% | 7.8% | ||
| Q2 25 | 4.2% | 8.1% | ||
| Q1 25 | 9.3% | 6.5% | ||
| Q4 24 | -57.0% | 10.6% | ||
| Q3 24 | -27.1% | 9.7% | ||
| Q2 24 | 10.7% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 7.4% | ||
| Q3 25 | 0.6% | 4.9% | ||
| Q2 25 | 2.7% | 5.0% | ||
| Q1 25 | 5.6% | 4.4% | ||
| Q4 24 | -51.1% | 7.1% | ||
| Q3 24 | -20.6% | 6.7% | ||
| Q2 24 | 4.0% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | $0.59 | $0.14 | ||
| Q3 25 | $-0.02 | $0.09 | ||
| Q2 25 | $0.06 | $0.08 | ||
| Q1 25 | $0.16 | $0.06 | ||
| Q4 24 | $-2.44 | $0.10 | ||
| Q3 24 | $-1.10 | $0.10 | ||
| Q2 24 | $0.13 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.2M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $518.4M | $141.5M |
| Total Assets | $4.8B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $228.2M | — | ||
| Q4 25 | $260.9M | $13.5M | ||
| Q3 25 | $238.8M | $11.1M | ||
| Q2 25 | $220.0M | $20.0M | ||
| Q1 25 | $279.4M | $10.2M | ||
| Q4 24 | $362.3M | $17.5M | ||
| Q3 24 | $359.8M | $11.3M | ||
| Q2 24 | $672.5M | $8.8M |
| Q1 26 | $518.4M | — | ||
| Q4 25 | $538.2M | $141.5M | ||
| Q3 25 | $503.6M | $133.6M | ||
| Q2 25 | $492.6M | $139.7M | ||
| Q1 25 | $484.5M | $134.8M | ||
| Q4 24 | $460.9M | $131.4M | ||
| Q3 24 | $530.3M | $125.0M | ||
| Q2 24 | $541.8M | $119.4M |
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.9B | $199.2M | ||
| Q3 25 | $5.0B | $202.4M | ||
| Q2 25 | $5.0B | $184.6M | ||
| Q1 25 | $4.9B | $178.1M | ||
| Q4 24 | $5.0B | $177.1M | ||
| Q3 24 | $5.0B | $169.5M | ||
| Q2 24 | $4.7B | $163.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.8M | $18.4M | ||
| Q3 25 | $34.3M | $18.4M | ||
| Q2 25 | $25.2M | $12.3M | ||
| Q1 25 | $-51.5M | $2.9M | ||
| Q4 24 | $-247.1M | $15.0M | ||
| Q3 24 | $-269.9M | $12.7M | ||
| Q2 24 | $-8.7M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-23.6M | $9.7M | ||
| Q3 25 | $33.7M | $10.7M | ||
| Q2 25 | $24.7M | $4.1M | ||
| Q1 25 | $-52.7M | $-12.6M | ||
| Q4 24 | $-252.0M | $3.2M | ||
| Q3 24 | $-270.8M | $1.7M | ||
| Q2 24 | $-9.3M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | 12.7% | ||
| Q3 25 | 19.5% | 14.9% | ||
| Q2 25 | 14.1% | 6.5% | ||
| Q1 25 | -30.6% | -21.4% | ||
| Q4 24 | -198.9% | 5.2% | ||
| Q3 24 | -141.4% | 3.0% | ||
| Q2 24 | -4.9% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.9% | 11.5% | ||
| Q3 25 | 0.4% | 10.6% | ||
| Q2 25 | 0.3% | 12.9% | ||
| Q1 25 | 0.7% | 26.2% | ||
| Q4 24 | 3.9% | 19.5% | ||
| Q3 24 | 0.4% | 19.0% | ||
| Q2 24 | 0.3% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | -0.59× | 3.27× | ||
| Q3 25 | 33.61× | 5.23× | ||
| Q2 25 | 5.29× | 3.88× | ||
| Q1 25 | -5.38× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | -1.14× | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
